Litfulo Capsule
Product Images NDC 0069-0334

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Litfulo (NDC 0069-0334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Litfulo 01)

Chemical structure diagram showing two molecular structures, one representing the active ingredient ritlecitinib and the other a sulfonic acid derivative, as part of the product Litfulo 50 mg oral capsules by Pfizer Laboratories.*

FDA Label Image

Figure 1 (Litfulo 02)

A line graph comparing the proportion of subjects with SALT 20 response over 24 weeks for Litfulo 50 mg once daily versus placebo. The vertical axis shows proportion percentages from 0 to 100, and the horizontal axis shows time in weeks from 0 to 24. The solid line representing Litfulo shows an increasing trend, while the dashed line representing placebo remains relatively flat.*

FDA Label Image

Logo (Litfulo 03)

FDA Label Image

Logo (Litfulo 04)

FDA Label Image

Principal Display Panel (50 mg Capsule Bottle Label)

Label for Litfulo (ritlecitinib) capsules 50 mg by Pfizer Laboratories Division of Pfizer Inc. The label includes storage instructions, dosage reference, and a warning not to crush, split, or chew the capsules. The package contains 28 capsules and is marked Rx only. The label also shows the NDC 0069-0334-28 and indicates the product is made in Ireland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.